Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Angers
Clinical trial register · France

Clinical Trials in Angers, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Angers 8 Amiens 4 Bobigny 4 Grenoble 4 Bayonne 4
Narrow the registerReset
Recruitment status
Phase
Site location
Angers8 Amiens4 Bobigny4 Grenoble4 Bayonne4
All 32 locations
Target enrolment
to

Trials with a site in Angers

8 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Momelotinib in VEXAS Syndrome
NCT07098936VEXAS Syndome, Myelo Dysplastic Syndrome
Groupe Francophone des Myelodysplasies
Phase 2
57
Angers, Clermont-Ferrand, Lille, Nantes, Paris, Pessac, Pierre-Bénite, Rennes
2025-11-25
Active, closed
Groupe Francophone des Myelodysplasies
Phase 1/2
36
Amiens, Angers, Bobigny, Cesson-Sévigné, Épagny, Grenoble, Le Mans, Lille
2023-12-06
Active, closed
Groupe Francophone des Myelodysplasies
Phase 2
44
Amiens, Angers, Bobigny, Cesson-Sévigné, Grenoble, Lille, Limoges, Mont-de-Marsan
2023-10-04
Active, closed
Groupe Francophone des Myelodysplasies
Phase 1/2
55
Angers, Grenoble, Limoges, Montpellier, Nantes, Nice, Paris, Pessac
2022-11-23
Recruiting
Groupe Francophone des Myelodysplasies
Phase 1/2
150
Amiens, Angers, Argenteuil, Avignon, Bayonne, Bobigny, Cesson-Sévigné, Compiègne
2022-05-18
Active, closed
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
NCT03503409Myelodysplastic Syndromes, Acute Myeloid Leukemia
Groupe Francophone des Myelodysplasies
Phase 2
68
Angers, Bayonne, Belfort, Caen, Grenoble, Le Mans, Limoges, Lyon
2019-05-14
Active, closed
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
NCT03744390Myelodysplastic Syndromes, Leukemia Acute Myeloid
Groupe Francophone des Myelodysplasies
Phase 2
68
Versailles, Montpellier, Angers, Argenteuil, Bayonne, Bordeaux, Caen, Créteil
2019-04-02
Active, closed
Groupe Francophone des Myelodysplasies
Phase 3
124
Amiens, Angers, Avignon, Bayonne, Belfort, Besançon, Bobigny, Brest
2018-03-26
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 3 November 2026. https://priyalifescience.com/clinical-trials-france/city/angers

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Angers that also match the filters currently applied.

How many clinical trials are recruiting in Angers?

2 of the 8 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Angers), 8 studies
PhaseStudiesRecruitingShare
Phase 24150%
Phase 1/23137.5%
Phase 31012.5%

Most active sponsors

Lead sponsors with the most studies (Angers)
Lead sponsorStudiesRecruiting
Groupe Francophone des Myelodysplasies82
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.